Literature DB >> 15684739

An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.

Réda Hadj-Slimane1, Mounira K Chelbi-Alix, Michael G Tovey, Pierre Bobé.   

Abstract

Lymphocytes from aged autoimmune MRL/lpr mice overexpress Fas ligand (FasL), and are cytotoxic against Fas+ target cells. This cytotoxic potential is only partly due to FasL, as wild-type MRL+/+ lymphocytes are not able to kill Fas+ targets after induction of FasL. In addition, serum levels of interferon-alpha (IFN-alpha) increase in parallel with the Fas-dependent cytotoxic potential of lymphocytes from MRL/lpr mice as they age. To understand the mechanisms underlying these observations, combined suppression subtractive hybridization (SSH) and RT-PCR were used to study differential gene expression in splenocytes from MRL/lpr mice compared with splenocytes from MRL+/+ mice. Twenty-two genes were upregulated transcriptionally in MRL/lpr splenocytes compared with their MRL+/+ counterparts. Furthermore, 9 of these genes were also upregulated after treatment of MRL/lpr splenocytes with IFN-alpha, and 4 were strongly downregulated. MRL/lpr lymphocytes were also found to be hyperresponsive to IFN-alpha. Thus, MRL/lpr lymphocytes overexpressed mRNA for the IFN-alpha receptor (IFNAR-1 and IFNAR-2) chains of the IFN-alpha/beta receptor and exhibited high endogenous levels of both Stat1 and phosphorylated Stat1 proteins. Lymphocytes from young MRL/lpr mice, with low Fas-dependent cytotoxic activity, were found to become highly cytotoxic against Fas+ targets after treatment with IFN-alpha. These data suggest that IFN-alpha plays an important role in the physiopathology of the systemic lupus erythematosus (SLE)-like syndrome that occurs in MRL/lpr mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15684739     DOI: 10.1089/jir.2004.24.717

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis.

Authors:  Sabrina Ceeraz; Petra A Sergent; Sean F Plummer; Alan R Schned; Dov Pechenick; Christopher M Burns; Randolph J Noelle
Journal:  Arthritis Rheumatol       Date:  2017-04       Impact factor: 10.995

Review 2.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

Review 3.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

4.  Phenotypic and functional alterations of pDCs in lupus-prone mice.

Authors:  Zhenyuan Zhou; Jianyang Ma; Chunyuan Xiao; Xiao Han; Rong Qiu; Yan Wang; Yingying Zhou; Li Wu; Xinfang Huang; Nan Shen
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

Review 5.  Emerging Topical and Systemic JAK Inhibitors in Dermatology.

Authors:  Farzan Solimani; Katharina Meier; Kamran Ghoreschi
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

6.  Sialoadhesin deficiency does not influence the severity of lupus nephritis in New Zealand black x New Zealand white F1 mice.

Authors:  Dana Kidder; Hannah E Richards; Paul A Lyons; Paul R Crocker
Journal:  Arthritis Res Ther       Date:  2013-11-01       Impact factor: 5.156

Review 7.  Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

Authors:  Takayuki Katsuyama; George C Tsokos; Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.